Global Tuberculosis Diagnostics and Treatment Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Tuberculosis Diagnostics and Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Tuberculosis Diagnostics and Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tuberculosis Diagnostics and Treatment market. Tuberculosis Diagnostics and Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tuberculosis Diagnostics and Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tuberculosis Diagnostics and Treatment market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Tuberculosis Diagnostics and Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tuberculosis Diagnostics and Treatment market. It may include historical data, market segmentation by Type (e.g., Skin Testing, Laboratory Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tuberculosis Diagnostics and Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tuberculosis Diagnostics and Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tuberculosis Diagnostics and Treatment industry. This include advancements in Tuberculosis Diagnostics and Treatment technology, Tuberculosis Diagnostics and Treatment new entrants, Tuberculosis Diagnostics and Treatment new investment, and other innovations that are shaping the future of Tuberculosis Diagnostics and Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tuberculosis Diagnostics and Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Tuberculosis Diagnostics and Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tuberculosis Diagnostics and Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tuberculosis Diagnostics and Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tuberculosis Diagnostics and Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tuberculosis Diagnostics and Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tuberculosis Diagnostics and Treatment market.
Market Segmentation:
Tuberculosis Diagnostics and Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Tuberculosis Diagnostics and Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Tuberculosis Diagnostics and Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tuberculosis Diagnostics and Treatment market. Tuberculosis Diagnostics and Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tuberculosis Diagnostics and Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tuberculosis Diagnostics and Treatment market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Tuberculosis Diagnostics and Treatment market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tuberculosis Diagnostics and Treatment market. It may include historical data, market segmentation by Type (e.g., Skin Testing, Laboratory Testing), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tuberculosis Diagnostics and Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tuberculosis Diagnostics and Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tuberculosis Diagnostics and Treatment industry. This include advancements in Tuberculosis Diagnostics and Treatment technology, Tuberculosis Diagnostics and Treatment new entrants, Tuberculosis Diagnostics and Treatment new investment, and other innovations that are shaping the future of Tuberculosis Diagnostics and Treatment.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tuberculosis Diagnostics and Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Tuberculosis Diagnostics and Treatment product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tuberculosis Diagnostics and Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tuberculosis Diagnostics and Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tuberculosis Diagnostics and Treatment market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tuberculosis Diagnostics and Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tuberculosis Diagnostics and Treatment market.
Market Segmentation:
Tuberculosis Diagnostics and Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Skin Testing
- Laboratory Testing
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cepheid Inc
- Becton Dickinson
- Hain LifeSciences
- Abbott Laboratories
- Alere, Inc
- Roche AG
- Hologic Corporation
- bioMerieux
- Sanofi
- QIAGEN
- Akonni Biosystems, Inc.
- Epistem Holdings Plc
- Gen-Probe Inc.
- EIKEN Chemical
- Thermo Fisher Scientific, Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Diagnostics and Treatment Market Size 2019-2030
2.1.2 Tuberculosis Diagnostics and Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tuberculosis Diagnostics and Treatment Segment by Type
2.2.1 Skin Testing
2.2.2 Laboratory Testing
2.3 Tuberculosis Diagnostics and Treatment Market Size by Type
2.3.1 Tuberculosis Diagnostics and Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
2.4 Tuberculosis Diagnostics and Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Tuberculosis Diagnostics and Treatment Market Size by Application
2.5.1 Tuberculosis Diagnostics and Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
3 TUBERCULOSIS DIAGNOSTICS AND TREATMENT MARKET SIZE BY PLAYER
3.1 Tuberculosis Diagnostics and Treatment Market Size Market Share by Players
3.1.1 Global Tuberculosis Diagnostics and Treatment Revenue by Players (2019-2024)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Diagnostics and Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS DIAGNOSTICS AND TREATMENT BY REGIONS
4.1 Tuberculosis Diagnostics and Treatment Market Size by Regions (2019-2024)
4.2 Americas Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.3 APAC Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.4 Europe Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
5.2 Americas Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
5.3 Americas Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024)
6.2 APAC Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
6.3 APAC Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tuberculosis Diagnostics and Treatment by Country (2019-2024)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Diagnostics and Treatment by Region (2019-2024)
8.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUBERCULOSIS DIAGNOSTICS AND TREATMENT MARKET FORECAST
10.1 Global Tuberculosis Diagnostics and Treatment Forecast by Regions (2025-2030)
10.1.1 Global Tuberculosis Diagnostics and Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Tuberculosis Diagnostics and Treatment Forecast
10.1.3 APAC Tuberculosis Diagnostics and Treatment Forecast
10.1.4 Europe Tuberculosis Diagnostics and Treatment Forecast
10.1.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Forecast
10.2 Americas Tuberculosis Diagnostics and Treatment Forecast by Country (2025-2030)
10.2.1 United States Tuberculosis Diagnostics and Treatment Market Forecast
10.2.2 Canada Tuberculosis Diagnostics and Treatment Market Forecast
10.2.3 Mexico Tuberculosis Diagnostics and Treatment Market Forecast
10.2.4 Brazil Tuberculosis Diagnostics and Treatment Market Forecast
10.3 APAC Tuberculosis Diagnostics and Treatment Forecast by Region (2025-2030)
10.3.1 China Tuberculosis Diagnostics and Treatment Market Forecast
10.3.2 Japan Tuberculosis Diagnostics and Treatment Market Forecast
10.3.3 Korea Tuberculosis Diagnostics and Treatment Market Forecast
10.3.4 Southeast Asia Tuberculosis Diagnostics and Treatment Market Forecast
10.3.5 India Tuberculosis Diagnostics and Treatment Market Forecast
10.3.6 Australia Tuberculosis Diagnostics and Treatment Market Forecast
10.4 Europe Tuberculosis Diagnostics and Treatment Forecast by Country (2025-2030)
10.4.1 Germany Tuberculosis Diagnostics and Treatment Market Forecast
10.4.2 France Tuberculosis Diagnostics and Treatment Market Forecast
10.4.3 UK Tuberculosis Diagnostics and Treatment Market Forecast
10.4.4 Italy Tuberculosis Diagnostics and Treatment Market Forecast
10.4.5 Russia Tuberculosis Diagnostics and Treatment Market Forecast
10.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Tuberculosis Diagnostics and Treatment Market Forecast
10.5.2 South Africa Tuberculosis Diagnostics and Treatment Market Forecast
10.5.3 Israel Tuberculosis Diagnostics and Treatment Market Forecast
10.5.4 Turkey Tuberculosis Diagnostics and Treatment Market Forecast
10.5.5 GCC Countries Tuberculosis Diagnostics and Treatment Market Forecast
10.6 Global Tuberculosis Diagnostics and Treatment Forecast by Type (2025-2030)
10.7 Global Tuberculosis Diagnostics and Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Information
11.1.2 Cepheid Inc Tuberculosis Diagnostics and Treatment Product Offered
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Cepheid Inc Main Business Overview
11.1.5 Cepheid Inc Latest Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Information
11.2.2 Becton Dickinson Tuberculosis Diagnostics and Treatment Product Offered
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Becton Dickinson Main Business Overview
11.2.5 Becton Dickinson Latest Developments
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Information
11.3.2 Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Offered
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Hain LifeSciences Main Business Overview
11.3.5 Hain LifeSciences Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Offered
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Alere, Inc
11.5.1 Alere, Inc Company Information
11.5.2 Alere, Inc Tuberculosis Diagnostics and Treatment Product Offered
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alere, Inc Main Business Overview
11.5.5 Alere, Inc Latest Developments
11.6 Roche AG
11.6.1 Roche AG Company Information
11.6.2 Roche AG Tuberculosis Diagnostics and Treatment Product Offered
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche AG Main Business Overview
11.6.5 Roche AG Latest Developments
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Information
11.7.2 Hologic Corporation Tuberculosis Diagnostics and Treatment Product Offered
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hologic Corporation Main Business Overview
11.7.5 Hologic Corporation Latest Developments
11.8 bioMerieux
11.8.1 bioMerieux Company Information
11.8.2 bioMerieux Tuberculosis Diagnostics and Treatment Product Offered
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 bioMerieux Main Business Overview
11.8.5 bioMerieux Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Tuberculosis Diagnostics and Treatment Product Offered
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Information
11.10.2 QIAGEN Tuberculosis Diagnostics and Treatment Product Offered
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 QIAGEN Main Business Overview
11.10.5 QIAGEN Latest Developments
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Information
11.11.2 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Offered
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Akonni Biosystems, Inc. Main Business Overview
11.11.5 Akonni Biosystems, Inc. Latest Developments
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Information
11.12.2 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Offered
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Epistem Holdings Plc Main Business Overview
11.12.5 Epistem Holdings Plc Latest Developments
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Information
11.13.2 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Offered
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Gen-Probe Inc. Main Business Overview
11.13.5 Gen-Probe Inc. Latest Developments
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Information
11.14.2 EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Offered
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EIKEN Chemical Main Business Overview
11.14.5 EIKEN Chemical Latest Developments
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Information
11.15.2 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Offered
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific, Inc Main Business Overview
11.15.5 Thermo Fisher Scientific, Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tuberculosis Diagnostics and Treatment Market Size 2019-2030
2.1.2 Tuberculosis Diagnostics and Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Tuberculosis Diagnostics and Treatment Segment by Type
2.2.1 Skin Testing
2.2.2 Laboratory Testing
2.3 Tuberculosis Diagnostics and Treatment Market Size by Type
2.3.1 Tuberculosis Diagnostics and Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
2.4 Tuberculosis Diagnostics and Treatment Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Tuberculosis Diagnostics and Treatment Market Size by Application
2.5.1 Tuberculosis Diagnostics and Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
3 TUBERCULOSIS DIAGNOSTICS AND TREATMENT MARKET SIZE BY PLAYER
3.1 Tuberculosis Diagnostics and Treatment Market Size Market Share by Players
3.1.1 Global Tuberculosis Diagnostics and Treatment Revenue by Players (2019-2024)
3.1.2 Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Tuberculosis Diagnostics and Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TUBERCULOSIS DIAGNOSTICS AND TREATMENT BY REGIONS
4.1 Tuberculosis Diagnostics and Treatment Market Size by Regions (2019-2024)
4.2 Americas Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.3 APAC Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.4 Europe Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024)
5.2 Americas Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
5.3 Americas Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024)
6.2 APAC Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
6.3 APAC Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Tuberculosis Diagnostics and Treatment by Country (2019-2024)
7.2 Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
7.3 Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tuberculosis Diagnostics and Treatment by Region (2019-2024)
8.2 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TUBERCULOSIS DIAGNOSTICS AND TREATMENT MARKET FORECAST
10.1 Global Tuberculosis Diagnostics and Treatment Forecast by Regions (2025-2030)
10.1.1 Global Tuberculosis Diagnostics and Treatment Forecast by Regions (2025-2030)
10.1.2 Americas Tuberculosis Diagnostics and Treatment Forecast
10.1.3 APAC Tuberculosis Diagnostics and Treatment Forecast
10.1.4 Europe Tuberculosis Diagnostics and Treatment Forecast
10.1.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Forecast
10.2 Americas Tuberculosis Diagnostics and Treatment Forecast by Country (2025-2030)
10.2.1 United States Tuberculosis Diagnostics and Treatment Market Forecast
10.2.2 Canada Tuberculosis Diagnostics and Treatment Market Forecast
10.2.3 Mexico Tuberculosis Diagnostics and Treatment Market Forecast
10.2.4 Brazil Tuberculosis Diagnostics and Treatment Market Forecast
10.3 APAC Tuberculosis Diagnostics and Treatment Forecast by Region (2025-2030)
10.3.1 China Tuberculosis Diagnostics and Treatment Market Forecast
10.3.2 Japan Tuberculosis Diagnostics and Treatment Market Forecast
10.3.3 Korea Tuberculosis Diagnostics and Treatment Market Forecast
10.3.4 Southeast Asia Tuberculosis Diagnostics and Treatment Market Forecast
10.3.5 India Tuberculosis Diagnostics and Treatment Market Forecast
10.3.6 Australia Tuberculosis Diagnostics and Treatment Market Forecast
10.4 Europe Tuberculosis Diagnostics and Treatment Forecast by Country (2025-2030)
10.4.1 Germany Tuberculosis Diagnostics and Treatment Market Forecast
10.4.2 France Tuberculosis Diagnostics and Treatment Market Forecast
10.4.3 UK Tuberculosis Diagnostics and Treatment Market Forecast
10.4.4 Italy Tuberculosis Diagnostics and Treatment Market Forecast
10.4.5 Russia Tuberculosis Diagnostics and Treatment Market Forecast
10.5 Middle East & Africa Tuberculosis Diagnostics and Treatment Forecast by Region (2025-2030)
10.5.1 Egypt Tuberculosis Diagnostics and Treatment Market Forecast
10.5.2 South Africa Tuberculosis Diagnostics and Treatment Market Forecast
10.5.3 Israel Tuberculosis Diagnostics and Treatment Market Forecast
10.5.4 Turkey Tuberculosis Diagnostics and Treatment Market Forecast
10.5.5 GCC Countries Tuberculosis Diagnostics and Treatment Market Forecast
10.6 Global Tuberculosis Diagnostics and Treatment Forecast by Type (2025-2030)
10.7 Global Tuberculosis Diagnostics and Treatment Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Cepheid Inc
11.1.1 Cepheid Inc Company Information
11.1.2 Cepheid Inc Tuberculosis Diagnostics and Treatment Product Offered
11.1.3 Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Cepheid Inc Main Business Overview
11.1.5 Cepheid Inc Latest Developments
11.2 Becton Dickinson
11.2.1 Becton Dickinson Company Information
11.2.2 Becton Dickinson Tuberculosis Diagnostics and Treatment Product Offered
11.2.3 Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Becton Dickinson Main Business Overview
11.2.5 Becton Dickinson Latest Developments
11.3 Hain LifeSciences
11.3.1 Hain LifeSciences Company Information
11.3.2 Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Offered
11.3.3 Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Hain LifeSciences Main Business Overview
11.3.5 Hain LifeSciences Latest Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Information
11.4.2 Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Offered
11.4.3 Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Abbott Laboratories Main Business Overview
11.4.5 Abbott Laboratories Latest Developments
11.5 Alere, Inc
11.5.1 Alere, Inc Company Information
11.5.2 Alere, Inc Tuberculosis Diagnostics and Treatment Product Offered
11.5.3 Alere, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Alere, Inc Main Business Overview
11.5.5 Alere, Inc Latest Developments
11.6 Roche AG
11.6.1 Roche AG Company Information
11.6.2 Roche AG Tuberculosis Diagnostics and Treatment Product Offered
11.6.3 Roche AG Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Roche AG Main Business Overview
11.6.5 Roche AG Latest Developments
11.7 Hologic Corporation
11.7.1 Hologic Corporation Company Information
11.7.2 Hologic Corporation Tuberculosis Diagnostics and Treatment Product Offered
11.7.3 Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hologic Corporation Main Business Overview
11.7.5 Hologic Corporation Latest Developments
11.8 bioMerieux
11.8.1 bioMerieux Company Information
11.8.2 bioMerieux Tuberculosis Diagnostics and Treatment Product Offered
11.8.3 bioMerieux Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 bioMerieux Main Business Overview
11.8.5 bioMerieux Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Tuberculosis Diagnostics and Treatment Product Offered
11.9.3 Sanofi Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Information
11.10.2 QIAGEN Tuberculosis Diagnostics and Treatment Product Offered
11.10.3 QIAGEN Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 QIAGEN Main Business Overview
11.10.5 QIAGEN Latest Developments
11.11 Akonni Biosystems, Inc.
11.11.1 Akonni Biosystems, Inc. Company Information
11.11.2 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Offered
11.11.3 Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Akonni Biosystems, Inc. Main Business Overview
11.11.5 Akonni Biosystems, Inc. Latest Developments
11.12 Epistem Holdings Plc
11.12.1 Epistem Holdings Plc Company Information
11.12.2 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Offered
11.12.3 Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Epistem Holdings Plc Main Business Overview
11.12.5 Epistem Holdings Plc Latest Developments
11.13 Gen-Probe Inc.
11.13.1 Gen-Probe Inc. Company Information
11.13.2 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Offered
11.13.3 Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Gen-Probe Inc. Main Business Overview
11.13.5 Gen-Probe Inc. Latest Developments
11.14 EIKEN Chemical
11.14.1 EIKEN Chemical Company Information
11.14.2 EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Offered
11.14.3 EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 EIKEN Chemical Main Business Overview
11.14.5 EIKEN Chemical Latest Developments
11.15 Thermo Fisher Scientific, Inc
11.15.1 Thermo Fisher Scientific, Inc Company Information
11.15.2 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Offered
11.15.3 Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Thermo Fisher Scientific, Inc Main Business Overview
11.15.5 Thermo Fisher Scientific, Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tuberculosis Diagnostics and Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Skin Testing
Table 3. Major Players of Laboratory Testing
Table 4. Tuberculosis Diagnostics and Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 7. Tuberculosis Diagnostics and Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 10. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Player (2019-2024)
Table 12. Tuberculosis Diagnostics and Treatment Key Players Head office and Products Offered
Table 13. Tuberculosis Diagnostics and Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tuberculosis Diagnostics and Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Regions (2019-2024)
Table 18. Global Tuberculosis Diagnostics and Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Country (2019-2024)
Table 22. Americas Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 24. Americas Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 26. APAC Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Table 28. APAC Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 30. APAC Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 32. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 36. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tuberculosis Diagnostics and Treatment
Table 45. Key Market Challenges & Risks of Tuberculosis Diagnostics and Treatment
Table 46. Key Industry Trends of Tuberculosis Diagnostics and Treatment
Table 47. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Cepheid Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 52. Cepheid Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 53. Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Cepheid Inc Main Business
Table 55. Cepheid Inc Latest Developments
Table 56. Becton Dickinson Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 57. Becton Dickinson Tuberculosis Diagnostics and Treatment Product Offered
Table 58. Becton Dickinson Main Business
Table 59. Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Becton Dickinson Latest Developments
Table 61. Hain LifeSciences Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 62. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Offered
Table 63. Hain LifeSciences Main Business
Table 64. Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Hain LifeSciences Latest Developments
Table 66. Abbott Laboratories Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 67. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Offered
Table 68. Abbott Laboratories Main Business
Table 69. Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Abbott Laboratories Latest Developments
Table 71. Alere, Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 72. Alere, Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 73. Alere, Inc Main Business
Table 74. Alere, Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alere, Inc Latest Developments
Table 76. Roche AG Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 77. Roche AG Tuberculosis Diagnostics and Treatment Product Offered
Table 78. Roche AG Main Business
Table 79. Roche AG Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Roche AG Latest Developments
Table 81. Hologic Corporation Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 82. Hologic Corporation Tuberculosis Diagnostics and Treatment Product Offered
Table 83. Hologic Corporation Main Business
Table 84. Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Hologic Corporation Latest Developments
Table 86. bioMerieux Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 87. bioMerieux Tuberculosis Diagnostics and Treatment Product Offered
Table 88. bioMerieux Main Business
Table 89. bioMerieux Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. bioMerieux Latest Developments
Table 91. Sanofi Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 92. Sanofi Tuberculosis Diagnostics and Treatment Product Offered
Table 93. Sanofi Main Business
Table 94. Sanofi Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Sanofi Latest Developments
Table 96. QIAGEN Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 97. QIAGEN Tuberculosis Diagnostics and Treatment Product Offered
Table 98. QIAGEN Main Business
Table 99. QIAGEN Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. QIAGEN Latest Developments
Table 101. Akonni Biosystems, Inc. Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 102. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Offered
Table 103. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Akonni Biosystems, Inc. Main Business
Table 105. Akonni Biosystems, Inc. Latest Developments
Table 106. Epistem Holdings Plc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 107. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Offered
Table 108. Epistem Holdings Plc Main Business
Table 109. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Epistem Holdings Plc Latest Developments
Table 111. Gen-Probe Inc. Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 112. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Offered
Table 113. Gen-Probe Inc. Main Business
Table 114. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Gen-Probe Inc. Latest Developments
Table 116. EIKEN Chemical Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 117. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Offered
Table 118. EIKEN Chemical Main Business
Table 119. EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. EIKEN Chemical Latest Developments
Table 121. Thermo Fisher Scientific, Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 122. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 123. Thermo Fisher Scientific, Inc Main Business
Table 124. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Thermo Fisher Scientific, Inc Latest Developments
Table 1. Tuberculosis Diagnostics and Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Skin Testing
Table 3. Major Players of Laboratory Testing
Table 4. Tuberculosis Diagnostics and Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 7. Tuberculosis Diagnostics and Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 10. Global Tuberculosis Diagnostics and Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Player (2019-2024)
Table 12. Tuberculosis Diagnostics and Treatment Key Players Head office and Products Offered
Table 13. Tuberculosis Diagnostics and Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Tuberculosis Diagnostics and Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Regions (2019-2024)
Table 18. Global Tuberculosis Diagnostics and Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Country (2019-2024)
Table 22. Americas Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 24. Americas Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 26. APAC Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Table 28. APAC Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 30. APAC Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 32. Europe Tuberculosis Diagnostics and Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 36. Europe Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Tuberculosis Diagnostics and Treatment
Table 45. Key Market Challenges & Risks of Tuberculosis Diagnostics and Treatment
Table 46. Key Industry Trends of Tuberculosis Diagnostics and Treatment
Table 47. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Tuberculosis Diagnostics and Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Cepheid Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 52. Cepheid Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 53. Cepheid Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Cepheid Inc Main Business
Table 55. Cepheid Inc Latest Developments
Table 56. Becton Dickinson Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 57. Becton Dickinson Tuberculosis Diagnostics and Treatment Product Offered
Table 58. Becton Dickinson Main Business
Table 59. Becton Dickinson Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Becton Dickinson Latest Developments
Table 61. Hain LifeSciences Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 62. Hain LifeSciences Tuberculosis Diagnostics and Treatment Product Offered
Table 63. Hain LifeSciences Main Business
Table 64. Hain LifeSciences Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Hain LifeSciences Latest Developments
Table 66. Abbott Laboratories Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 67. Abbott Laboratories Tuberculosis Diagnostics and Treatment Product Offered
Table 68. Abbott Laboratories Main Business
Table 69. Abbott Laboratories Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Abbott Laboratories Latest Developments
Table 71. Alere, Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 72. Alere, Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 73. Alere, Inc Main Business
Table 74. Alere, Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Alere, Inc Latest Developments
Table 76. Roche AG Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 77. Roche AG Tuberculosis Diagnostics and Treatment Product Offered
Table 78. Roche AG Main Business
Table 79. Roche AG Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Roche AG Latest Developments
Table 81. Hologic Corporation Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 82. Hologic Corporation Tuberculosis Diagnostics and Treatment Product Offered
Table 83. Hologic Corporation Main Business
Table 84. Hologic Corporation Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Hologic Corporation Latest Developments
Table 86. bioMerieux Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 87. bioMerieux Tuberculosis Diagnostics and Treatment Product Offered
Table 88. bioMerieux Main Business
Table 89. bioMerieux Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. bioMerieux Latest Developments
Table 91. Sanofi Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 92. Sanofi Tuberculosis Diagnostics and Treatment Product Offered
Table 93. Sanofi Main Business
Table 94. Sanofi Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Sanofi Latest Developments
Table 96. QIAGEN Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 97. QIAGEN Tuberculosis Diagnostics and Treatment Product Offered
Table 98. QIAGEN Main Business
Table 99. QIAGEN Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. QIAGEN Latest Developments
Table 101. Akonni Biosystems, Inc. Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 102. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Product Offered
Table 103. Akonni Biosystems, Inc. Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Akonni Biosystems, Inc. Main Business
Table 105. Akonni Biosystems, Inc. Latest Developments
Table 106. Epistem Holdings Plc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 107. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Product Offered
Table 108. Epistem Holdings Plc Main Business
Table 109. Epistem Holdings Plc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Epistem Holdings Plc Latest Developments
Table 111. Gen-Probe Inc. Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 112. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Product Offered
Table 113. Gen-Probe Inc. Main Business
Table 114. Gen-Probe Inc. Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 115. Gen-Probe Inc. Latest Developments
Table 116. EIKEN Chemical Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 117. EIKEN Chemical Tuberculosis Diagnostics and Treatment Product Offered
Table 118. EIKEN Chemical Main Business
Table 119. EIKEN Chemical Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 120. EIKEN Chemical Latest Developments
Table 121. Thermo Fisher Scientific, Inc Details, Company Type, Tuberculosis Diagnostics and Treatment Area Served and Its Competitors
Table 122. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Product Offered
Table 123. Thermo Fisher Scientific, Inc Main Business
Table 124. Thermo Fisher Scientific, Inc Tuberculosis Diagnostics and Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 125. Thermo Fisher Scientific, Inc Latest Developments
LIST OF FIGURES
Figure 1. Tuberculosis Diagnostics and Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tuberculosis Diagnostics and Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tuberculosis Diagnostics and Treatment Sales Market Share by Country/Region (2023)
Figure 8. Tuberculosis Diagnostics and Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type in 2023
Figure 10. Tuberculosis Diagnostics and Treatment in Hospital
Figure 11. Global Tuberculosis Diagnostics and Treatment Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Tuberculosis Diagnostics and Treatment in Clinic
Figure 13. Global Tuberculosis Diagnostics and Treatment Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Tuberculosis Diagnostics and Treatment in Other
Figure 15. Global Tuberculosis Diagnostics and Treatment Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application in 2023
Figure 17. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Player in 2023
Figure 18. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Tuberculosis Diagnostics and Treatment Value Market Share by Country in 2023
Figure 24. United States Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Application in 2023
Figure 31. China Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Tuberculosis Diagnostics and Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tuberculosis Diagnostics and Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Tuberculosis Diagnostics and Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Tuberculosis Diagnostics and Treatment Sales Market Share by Country/Region (2023)
Figure 8. Tuberculosis Diagnostics and Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Type in 2023
Figure 10. Tuberculosis Diagnostics and Treatment in Hospital
Figure 11. Global Tuberculosis Diagnostics and Treatment Market: Hospital (2019-2024) & ($ Millions)
Figure 12. Tuberculosis Diagnostics and Treatment in Clinic
Figure 13. Global Tuberculosis Diagnostics and Treatment Market: Clinic (2019-2024) & ($ Millions)
Figure 14. Tuberculosis Diagnostics and Treatment in Other
Figure 15. Global Tuberculosis Diagnostics and Treatment Market: Other (2019-2024) & ($ Millions)
Figure 16. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Application in 2023
Figure 17. Global Tuberculosis Diagnostics and Treatment Revenue Market Share by Player in 2023
Figure 18. Global Tuberculosis Diagnostics and Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Tuberculosis Diagnostics and Treatment Value Market Share by Country in 2023
Figure 24. United States Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Tuberculosis Diagnostics and Treatment Market Size Market Share by Application in 2023
Figure 31. China Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Tuberculosis Diagnostics and Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Tuberculosis Diagnostics and Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Tuberculosis Diagnostics and Treatment Market Size Market Share Forecast by Application (2025-2030)
